about
Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells.Modeling, design and synthesis of new heteroaryl ethylenes active against the MCF-7 breast cancer cell-line.Resveratrol-Related Polymethoxystilbene Glycosides: Synthesis, Antiproliferative Activity, and Glycosidase Inhibition.Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoidsDihydrobenzofuran Neolignanamides: Laccase-Mediated Biomimetic Synthesis and Antiproliferative Activity.Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer.Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2.Chromosomal instability analysis and regional tumor heterogeneity in colon cancer.In vitro combined treatment with cetuximab and trastuzumab inhibits growth of colon cancer cells.Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.Design, synthesis and in vitro antitumour activity of new heteroaryl ethylenes.Design, synthesis and biological evaluation of trans 2-(thiophen-2-yl)vinyl heteroaromatic iodides.Design and synthesis of trans 2-(furan-2-yl)vinyl heteroaromatic iodides with antitumour activity.Identification of genes involved in the sensitivity to antitumour drug 17-allylamino,17-demethoxygeldanamycin (17AAG).Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides.Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy.Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress.Identification of calcium sensing receptor (CaSR) mRNA-expressing cells in normal and injured rat brain.In vitro antitumor activities of 2,6-di-[2-(heteroaryl)vinyl]pyridines and pyridiniums.Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice).Antiproliferative terpenoids from almond hulls (Prunus dulcis): identification and structure-activity relationships.Tissue-specific DNA methylation patterns of the rat glial fibrillary acidic protein gene.Juvenile elastoma without germline mutations in LEMD3 gene: A case of Buschke-Ollendorff syndrome?Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells.Growth conditions differentially affect the constitutive expression of primary response genes in cultured cerebellar granule cells.Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture.Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal CancerSomatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromasBio-inspired benzo[k,l]xanthene lignans: synthesis, DNA-interaction and antiproliferative propertiesGene expression profiles in genome instability-based classes of colorectal cancerAMPA-selective glutamate receptor subunits in astroglial culturesGFAP gene methylation in different neural cell types from rat brainGenome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DAClonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AMLICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery diseaseTranscriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer
P50
Q33625532-68DF1A79-5461-4580-B299-E688F00EAB01Q33653352-6BB85C3F-44DE-4B7D-B859-57D06E492973Q34881760-E484A41A-60F6-4460-BA91-18F8BF6CD1B7Q35833195-5CDB23A0-1742-49CC-8500-D89CFB149C51Q36095911-ACACE8AC-7C41-425E-ABCE-2ABF50EA582BQ36098482-EA628FBE-E8D6-4440-96E4-6000C782DF53Q37148790-7DFC33B8-2CA5-4406-90DA-CD59019C61BBQ38341497-1AB6D689-EDD8-484D-A90C-CE8B36A3C9FCQ38801817-F342D46B-DEE8-429B-9B6E-9080328AF6F1Q38905987-5E13C695-975D-4000-8C3D-9C22A0FC908CQ38954963-0D81CB8F-E6D2-4B72-88B6-38E41AB75497Q38965084-CC08FD16-FD4E-4433-8CA9-3A39C85CF615Q39431566-789C95A8-19FF-40E9-8FDA-E9D4CF25AA27Q39437088-4D8887EE-9651-42AF-AD92-693798DA0D98Q39701828-D0E11C07-6B29-4589-9340-C6CEF8B9A58AQ40016720-550DB9A3-545B-4192-BD05-4C6838D31CD7Q40249332-F69B709D-87B2-4E46-ACD8-FB18F2C17D55Q40577256-51BF41AE-5BF6-436F-84D6-9E263CAFBC37Q40651485-8654EB4B-2C2B-4188-847A-DB40F403B3A5Q42835885-EE75F685-0F79-4A99-BE84-FCDB31D1E04EQ43281308-EC40FBB9-5EED-4A82-A598-719E895EC54DQ44057880-FC0E0F12-2F42-4437-BA56-32625EC1000BQ46528783-049B737D-E102-4A5F-8DF4-7D98F0534763Q46920429-09CA8B26-1E72-47B2-9225-6F4AC092D674Q48077020-7FF5CAEA-5867-4E28-A1A9-8F3541F15DA7Q48201514-D2B399C2-F987-40F5-9FC9-8D7B5F71C8D8Q49918425-FE19F321-6046-4752-B76A-18D30FA6333EQ52208651-574AE996-E7D8-46E7-8044-FB89CCCDD694Q52211395-1EC5E912-2151-4703-A0C6-7510C8154E26Q57031949-0BA686C5-7EF8-42EE-A49F-0A9E31C59B5FQ57754094-05F397AC-DA02-468D-89CB-8F51C0D6762FQ59237320-8C527014-C002-4886-9784-6283B3A1AABEQ60044024-A9E32F69-767C-4619-A9B7-DA3424625417Q72682264-24E670C6-561C-4FBA-92E8-5E509CDC1D0CQ73262902-F88947C3-65CC-4C6B-A0F1-4793119ECAB3Q81889275-4FF98467-06B3-463A-A1E8-FFE93B388AEBQ84626274-675EA515-CDDD-4C2D-92F0-729E50A1F88EQ87988845-42162451-3A03-4199-8C3D-DC9CBC28504CQ91056980-4E517B2D-A282-4F0F-83AB-C600A3637CDE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vincenza Barresi
@ast
Vincenza Barresi
@en
Vincenza Barresi
@es
Vincenza Barresi
@nl
type
label
Vincenza Barresi
@ast
Vincenza Barresi
@en
Vincenza Barresi
@es
Vincenza Barresi
@nl
prefLabel
Vincenza Barresi
@ast
Vincenza Barresi
@en
Vincenza Barresi
@es
Vincenza Barresi
@nl
P106
P1153
6701388363
P31
P496
0000-0003-1183-6981